Dermapharm Holding SE buy Snowman
Start price
16.06.21
/
50%
€71.65
Target price
16.06.22
€86.00
Performance (%)
-30.50%
End price
20.05.22
€49.80
Summary
This prediction ended on 20.05.22 with a price of €49.80. Massive losses of -30.50% were the result for the BUY prediction by Snowman. Snowman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 0.320% | 0.320% | 27.027% | 0.902% |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % | 51,11 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % | 91,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % | 65,85 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % | 66,64 % |
Comments by Snowman for this prediction
In the thread Dermapharm Holding SE diskutieren
Kursziel geändert auf 86,0